| Trial registration number
|
EUCTR2021-000893-27-BE |
Full text link
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
https://www.clinicaltrialsregister.eu/ctr-search/trial/2021-000893-27/BE
|
First author
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
AZ SInt-Jan Brugge-Oostende AV - Clinical Trial Center
|
Contact
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
ctc@azsintjan.be
|
Registration date
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
2021-03-04
|
Recruitment status
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
Recruiting
|
Study design
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
nonRCT
|
Allocation
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
Non-randomized
|
Design
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
Single group assignment
|
Masking
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
Open label
|
Center
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
single-center
|
Study aim
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
Prevention
|
Inclusion criteria
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
- health care employees (or patients)
- 18 years or older
- voluntarily receiving vaccination
- pregnant or lactating
|
Exclusion criteria
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
- not eligible according to the inclusion criteria
|
Number of arms
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
1
|
Funding
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
AZ Sint-Jan Brugge-Oostende AV
|
Inclusion age min
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
18
|
Inclusion age max
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
100
|
Countries
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
Belgium
|
Type of patients
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
Health workers
|
Severity scale
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
N/A
|
Total sample size
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
15
|
primary outcome
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
presence and amount of IGM and IgG or IgA antibodies
|
Notes
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
Declared number of arm (1.0)
differs from found arms (2.0)
|
Phase
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
Phase 4
|
Arms
Last imported at : April 28, 2021, 3:52 p.m.
Source : EU Clinical Trials Register
|
[{"arm_notes": "2;pregnant or lactating", "treatment_id": 339, "treatment_name": "Covid-19 mrna vaccine (nucleoside-modified)", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}]
|